MiR-23b-3p ameliorates sepsis-induced acute lung injury by inhibiting SMAD3-mediated endothelial-mesenchymal transition

Abstract

Background: Sepsis-associated acute lung injury (ALI) is driven by endothelial barrier dysfunction and endothelial–mesenchymal transition (EndoMT), mediated by TGF-β1/SMAD3 signaling. Despite the therapeutic potential of SMAD3, current inhibitors face limitations. As endogenous small molecules that are closely related to physiological regulatory processes, microRNAs (miRNAs) have more potential research value for regulating SMAD3. Therefore, this study aimed to investigate the protective effect and molecular mechanism of a key miRNA targeting SMAD3 in sepsis-ALI. Methods: Screening multiple databases revealed that miR-23b-3p was the sole miRNA targeting SMAD3. Lipopolysaccharide (LPS)-stimulated human umbilical vein endothelial cells (HUVECs) and cecal ligation/puncture (CLP) mice were used to model sepsis. Lentivirus was used to construct stable strains. The functional performance and mechanism were verified by key techniques, including dual-luciferase assays, rescue experiments, reverse transcription–quantitative polymerase chain reaction (qPCR)/Western blotting, monocyte adhesion/permeability assays, and histopathology. Results: In LPS-stimulated HUVECs, miR-23b-3p downregulation correlated with TGF-β1/SMAD3 activation, EndoMT progression, and barrier disruption. miR-23b-3p overexpression reversed these effects by restoring the expression of junctional proteins and suppressing the expression of mesenchymal markers. Chromatin isolation by RNA purification–qPCR, RNA pull-down, and dual-luciferase assays confirmed the direct miR-23b-3p-SMAD3 3′UTR interaction. Rescue experiments demonstrated that miR-23b-3p counteracts TGF-β1/SMAD3 hyperactivation. In CLP mice, intratracheal agomiR-23b-3p attenuated lung injury, normalized alveolar architecture, and reduced vascular leakage by suppressing endothelial Smad3 upregulation. Conclusion: miR-23b-3p is a SMAD3-targeting regulator that inhibits EndoMT and repairs endothelial barrier integrity. Mechanistically, miR-23b-3p preserves endothelial homeostasis via SMAD3-dependent EndoMT inhibition. This study provides mechanistic insights and a miRNA-based therapeutic strategy for sepsis-induced ALI.

Keywords

Sepsis / Acute lung injury / Endothelial cells / MiR-23b-3p / TGF-β1/SMAD3 / EndoMT

References

[1] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315: 801-10. https://doi.org/10.1001/jama.2016.0287.

[2] Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet. 2020; 395: 200-11. https://doi.org/10.1016/S0140-6736(19)32989-7.

[3] Ren C, Yao R-Q, Zhang H, Feng Y-W, Yao Y-M. Sepsis-associated encephalopathy: a vicious cycle of immunosuppression. J Neuroinflammation. 2020; 17: 14. https://doi.org/10.1186/s12974-020-1701-3.

[4] Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019; 96: 1083-99. https://doi.org/10.1016/j.kint.2019.05.026.

[5] Iba T, Levi M, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost. 2020; 46: 89-95. https://doi.org/10.1055/s-0039-1694995.

[6] Liu B, Li N, Liu Y, Zhang Y, Qu L, Cai H, et al. BRD3308 suppresses macrophage oxidative stress and pyroptosis via upregulating acetylation of H3K27 in sepsis-induced acute lung injury. Burns Trauma. 2024; 12: tkae033. https://doi.org/10.1093/burnst/tkae033.

[7] Xie J, Wang H, Kang Y, Zhou L, Liu Z, Qin B, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey. Crit Care Med. 2020; 48: e209-18. https://doi.org/10.1097/CCM.0000000000004155.

[8] Lee WL, Slutsky AS. Sepsis and endothelial permeability. N Engl J Med. 2010; 363: 689-91. https://doi.org/10.1056/NEJMcibr1007320.

[9] Joffre J, Hellman J, Ince C, Ait-Oufella H. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020; 202: 361-70. https://doi.org/10.1164/rccm.201910-1911TR.

[10] Lelubre C, Vincent J-L. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018; 14: 417-27. https://doi.org/10.1038/s41581-018-0005-7.

[11] Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021; 73: 924-67. https://doi.org/10.1124/pharmrev.120.000096.

[12] Eapen MS, Lu W, Gaikwad AV, Bhattarai P, Chia C, Hardikar A, et al. Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Eur Respir J. 2020; 56: 2003167. https://doi.org/10.1183/13993003.03167-2020.

[13] Sun X, Nkennor B, Mastikhina O, Soon K, Nunes SS. Endothelium-mediated contributions to fibrosis. Semin Cell Dev Biol. 2020; 101: 78-86. https://doi.org/10.1016/j.semcdb.2019.10.015.

[14] Goumans M-J, van Zonneveld AJ, ten Dijke P. Transforming growth factor β-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis? Trends Cardiovasc Med. 2008; 18: 293-8. https://doi.org/10.1016/j.tcm.2009.01.001.

[15] Suzuki T, Tada Y, Nishimura R, Kawasaki T, Sekine A, Urushibara T, et al. Endothelial-to-mesenchymal transition in lipopolysaccharide-induced acute lung injury drives a progenitor cell-like phenotype. Am J Physiol Lung Cell Mol Physiol. 2016; 310: L1185-98. https://doi.org/10.1152/ajplung.00074.2016.

[16] Wyman AE, Nguyen TTT, Karki P, Tulapurkar ME, Zhang C-O, Kim J, et al. SIRT7 deficiency suppresses inflammation, induces EndoMT, and increases vascular permeability in primary pulmonary endothelial cells. Sci Rep. 2020; 10: 12497. https://doi.org/10.1038/s41598-020-69236-z.

[17] Kitao A, Sato Y, Sawada-Kitamura S, Harada K, Sasaki M, Morikawa H, et al. Endothelial to mesenchymal transition via transforming growth factor-β1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am J Pathol. 2009; 175: 616-26. https://doi.org/10.2353/ajpath.2009.081061.

[18] Zhang C, Lu W, Luo X, Liu S, Li Y, Zheng Q, et al. Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats. Br J Pharmacol. 2021; 178: 217-35. https://doi.org/10.1111/bph.15314.

[19] Yang C-C, Sung P, Chen C-H, Chiang JY, Shao P-L, Wu S-C, et al. Additional benefit of induced pluripotent stem cell-derived mesenchymal stem cell therapy on sepsis syndrome-associated acute kidney injury in rat treated with antibiotic. Stem Cell Res Ther. 2021; 12: 526. https://doi.org/10.1186/s13287-021-02582-5.

[20] Li L-F, Lee C-S, Liu Y-Y, Chang C-H, Lin C-W, Chiu L-C, et al. Activation of Src-dependent Smad3 signaling mediates the neutrophilic inflammation and oxidative stress in hyperoxia-augmented ventilator-induced lung injury. Respir Res. 2015; 16: 112. https://doi.org/10.1186/s12931-015-0275-6.

[21] Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007; 23: 175-205. https://doi.org/10.1146/annurev.cellbio.23.090506.123406.

[22] Li W, Chen L, Gu Z, Chen Z, Li H, Cheng Z, et al. Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD). J Control Release. 2023; 355: 358-70. https://doi.org/10.1016/j.jconrel.2023.01.080.

[23] Lin J, Yang L, Liu T, Zhao H, Liu Y, Shu F, et al. Mannose-modified exosomes loaded with MiR-23b-3p target alveolar macrophages to alleviate acute lung injury in sepsis. J Control Release. 2025; 379: 832-47. https://doi.org/10.1016/j.jconrel.2025.01.073.

[24] Sun J, Ge X, Wang Y, Niu L, Tang L, Pan S. USF2 knockdown downregulates THBS1 to inhibit the TGF-β signaling pathway and reduce pyroptosis in sepsis-induced acute kidney injury. Pharmacol Res. 2022; 176: 105962. https://doi.org/10.1016/j.phrs.2021.105962.

[25] Li J, Qu X, Yao J, Caruana G, Ricardo SD, Yamamoto Y, et al. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes. 2010; 59: 2612-24. https://doi.org/10.2337/db09-1631.

[26] Hsu S-D, Lin F-M, Wu W-Y, Liang C, Huang W-C, Chan W-L, et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 2011; 39: D163-9. https://doi.org/10.1093/nar/gkq1107.

[27] Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015; 43: W460-6. https://doi.org/10.1093/nar/gkv403.

[28] Agarwal V, Bell GW, Nam J-W, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015; 4: e05005. https://doi.org/10.7554/eLife.05005.

[29] Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014; 42: D92-7. https://doi.org/10.1093/nar/gkt1248.

[30] Wu T, Wang J, Liu C, Zhang Y, Shi B, Zhu X, et al. NPInter: the noncoding RNAs and protein related biomacromolecules interaction database. Nucleic Acids Res. 2006; 34: D150-2. https://doi.org/10.1093/nar/gkj025.

[31] Philippe B, Jérôme M, Frédéric E, Christophe D, Christophe K. Jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014; 15: 293. https://doi.org/10.1186/1471-2105-15-293.

[32] Li Y, Zhao Y, Song L, Xiong L, Li W, Wu W, et al. High glucose levels contribute to vascular fibrosis via the activation of the endothelial-to-mesenchymal transition in periodontitis. J Periodontal Res. 2023; 58: 225-36. https://doi.org/10.1111/jre.13084.

[33] Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97. https://doi.org/10.1016/S0092-8674(04)00045-5.

[34] Chen J, Liu A, Wang Z, Wang B, Chai X, Lu W, et al. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression. Mol Cancer. 2020; 19: 98. https://doi.org/10.1186/s12943-020-01217-2.

[35] Willenberg I, Rund K, Rong S, Shushakova N, Gueler F, Schebb NH. Characterization of changes in plasma and tissue oxylipin levels in LPS and CLP induced murine sepsis. Inflamm Res. 2016; 65: 133-42. https://doi.org/10.1007/s00011-015-0897-7.

[36] Gao H, Xiao D, Gao L, Li X. MicroRNA-93 contributes to the suppression of lung inflammatory responses in LPS-induced acute lung injury in mice via the TLR4/MyD88/NF-κB signaling pathway. Int J Mol Med. 2020; 46: 561-70. https://doi.org/10.3892/ijmm.2020.4610.

[37] Kuklin V, Sovershaev M, Bjerner J, Keith P, Scott LK, Thomas OMT, et al. Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis. Crit Care. 2024; 28: 12. https://doi.org/10.1186/s13054-023-04795-x.

[38] Xu P, Bailey-Bucktrout S, Xi Y, Xu D, Du D, Zhang Q, et al. Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling. Mol Cell. 2014; 56: 723-37. https://doi.org/10.1016/j.molcel.2014.11.027.

[39] He H, Zhang W, Jiang L, Tong X, Zheng Y, Xia Z. Endothelial cell dysfunction due to molecules secreted by macrophages in sepsis. Biomolecules. 2024; 14: 980. https://doi.org/10.3390/biom14080980.

[40] Chen X, Qi D, Fan S, He Y, Jing H, Wang D. Interferon regulatory factor 1 (IRF1) inhibits lung endothelial regeneration following inflammation-induced acute lung injury. Clin Sci. 2023; 137: 367-83. https://doi.org/10.1042/CS20220876.

[41] Cambria E, Blazeski A, Ko EC, Thai T, Dantes S, Barbie DA, et al. Myofibroblasts reduce angiogenesis and vasculogenesis in a vascularized microphysiological model of lung fibrosis. bioRxiv [Preprint]. 2025. https://doi.org/10.1101/2025.01.10.632378.

[42] Zhang W, Jiang L, Tong X, He H, Zheng Y, Xia Z. Sepsis-induced endothelial dysfunction: permeability and regulated cell death. JIR. 2024; 17: 9953-73. https://doi.org/10.2147/JIR.S479926.

[43] Jan M, Cueto R, Jiang X, Lu L, Sardy J, Xiong X, et al. Molecular processes mediating hyperhomocysteinemia-induced metabolic reprogramming, redox regulation and growth inhibition in endothelial cells. Redox Biol. 2021; 45: 102018. https://doi.org/10.1016/j.redox.2021.102018.

[44] Jiang T, Liu E, Li Z, Yan C, Zhang X, Guan J, et al. SIRT1-Rab7 axis attenuates NLRP3 and STING activation through late endosomal-dependent mitophagy during sepsis-induced acute lung injury. Int J Surg. 2024; 110: 2649-68. https://doi.org/10.1097/JS9.0000000000001215.